Dyspareunia in Women With Endometriosis: Impact of Surgery on Sexual Health

U

University of Cagliari

Status

Unknown

Conditions

Dyspareunia
Endometriosis

Treatments

Behavioral: Questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT02484196
ENDODISP14

Details and patient eligibility

About

Endometriosis is a disease that affects different areas of individual functioning, including the area of sexual life. Women with endometriosis have an impairment of desire and sexual arousal, orgasmic capacity reducted because of the pain and deep dyspareunia. The aim of the study is to evaluate the effectiveness of surgery on dyspareunia in women with endometriosis, taking into account other variables involved in determining dyspareunia: the quality of the couple relationship, anxiety and depression, body image, coping strategies and resilience.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women affected by endometriosis with dyspareunia;
  • Women in waiting list for surgery

Exclusion criteria

  • Severe underlying comorbidities (gynecological, cardiovascular, respiratory, renal, hematological, endocrine, hepatic, gastrointestinal, neurological)
  • Psychiatric diseases
  • Refusal or inability to sign the informed consent
  • Pregnancy
  • Previous gynecological surgery
  • End of couple relationship

Trial design

100 participants in 2 patient groups

Couples
Description:
Women, with their partners, referred to the Obstetrics and Gynecological Department of the University Hospital for surgical treatment of endometriosis.
Treatment:
Behavioral: Questionnaires
Women
Description:
Women referred to the Obstetrics and Gynecological Department of the University Hospital for surgical treatment of endometriosis.
Treatment:
Behavioral: Questionnaires

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems